surface cd33 ac104 3 e3 142 miltenyi 4 3 surface cd11c (Miltenyi Biotec)
Structured Review
Surface Cd33 Ac104 3 E3 142 Miltenyi 4 3 Surface Cd11c, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33+car+detection+reagent/CD33+CAR+Detection+Reagent%2C+human/pmc12477255__Supplementaryfile1-19-40-44
Average 93 stars, based on 3 article reviews
Images
Related Articles
Expressing:Article Title: Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia Article Snippet: GFP-positive tumor cells or CD56 and CD33-CAR expression were analyzed using a BD FACSCelesta flow cytometer. .. An anti-CD56-BV786 antibody (Clone NCAM16.2, BD Biosciences) and a Staining:Article Title: CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells Article Snippet: .. Subsequently, cells were stained with an anti-NKG2A-PE antibody (Clone Z199, Beckman Coulter), Article Title: CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells. Article Snippet: .. Subsequently, cells were stained with an anti-NKG2A-PE antibody (Clone Z199, Beckman Coulter), Labeling:Article Title: CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells Article Snippet: .. Subsequently, cells were stained with an anti-NKG2A-PE antibody (Clone Z199, Beckman Coulter), Article Title: CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells. Article Snippet: .. Subsequently, cells were stained with an anti-NKG2A-PE antibody (Clone Z199, Beckman Coulter), Single Cell:Article Title: CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells Article Snippet: .. Subsequently, cells were stained with an anti-NKG2A-PE antibody (Clone Z199, Beckman Coulter), Multiplexing:Article Title: CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells Article Snippet: .. Subsequently, cells were stained with an anti-NKG2A-PE antibody (Clone Z199, Beckman Coulter), |
